chr12-109401159-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001101421.4(MYO1H):c.637G>A(p.Glu213Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101421.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO1H | NM_001101421.4 | c.637G>A | p.Glu213Lys | missense_variant | 6/32 | ENST00000310903.10 | |
MYO1H | XM_011538223.3 | c.589G>A | p.Glu197Lys | missense_variant | 7/34 | ||
MYO1H | XM_047428738.1 | c.589G>A | p.Glu197Lys | missense_variant | 5/31 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO1H | ENST00000310903.10 | c.637G>A | p.Glu213Lys | missense_variant | 6/32 | 5 | NM_001101421.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249070Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135106
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461646Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727096
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.589G>A (p.E197K) alteration is located in exon 5 (coding exon 5) of the MYO1H gene. This alteration results from a G to A substitution at nucleotide position 589, causing the glutamic acid (E) at amino acid position 197 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at